ArticleBMC cancer2023

Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma.

Zhuoya Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.